The US-backed vaccine trial for newborns in Africa aimed at combating hepatitis B was halted due to global backlash.

Healthcare International RelationsOct 21, 2026score 0.272 posts · 0 replies across 2 instances

A US-backed vaccine trial for newborns in Africa, aimed at combating hepatitis B, has been halted due to global backlash. The trial, which was to be funded by the CDC, faced controversy and will not proceed. This highlights concerns about international medical research ethics and funding.

Claims

Parent: HealthcareEntity: Vaccine TrialsSub-entity: Hepatitis BImpact: negativeDate: Oct 21, 2026 - Oct 22, 2026Target: The continuation of the US-backed vaccine trial for newborns in Africa

Source posts

@[email protected]

Controversial US-backed vaccine trial in African newborns halted https://www.theguardian.com/world/2026/oct/21/us-vaccine-trial-african-newborns-hepatitis-b
#RSSFeed

0 boosts · 0 favs · 0 replies · Oct 21, 2026

#rssfeed

@[email protected]

Controversial US-backed vaccine trial in African newborns halted. Hepatitis B study in Guinea-Bissau that was to be funded by CDC and that drew global backlash ‘will not move forward’. | The Guardian https://www.theguardian.com/world/2026/oct/21/us-vaccine-trial-african-newborns-hepatitis-b

0 boosts · 0 favs · 0 replies · Oct 22, 2026